Table 4.
Factors associated with vaso-occlusive crises in the SIT Trial
Covariate | ACS |
Pain |
||
---|---|---|---|---|
Rate | P | Rate | P | |
% fetal hemoglobin* | < .0001 | .23 | ||
Sex | ||||
Male | 0.17 | .005 | 0.68 | .07 |
Female | 0.12 | 0.58 | ||
Asthma diagnosis | ||||
Yes | 0.21 | < .0001 | 0.74 | .02 |
No | 0.12 | 0.59 | ||
α-globin genotype† | ||||
αα/αα | 0.15 | 0.56 | ||
α/αα | 0.14 | .41 | 0.69 | .03 |
α/-α | 0.08 | .07 | 0.88 | .02 |
P values derived from the regression of ACS or pain on the log transformation of fetal hemoglobin.
Persons with αα/ααα genotypes carried no gene deletions and were grouped with αα/αα for analysis.